Folinic Acid for Autism in Children (2 mg/kg/day)
Official title: Folinic Acid as a Treatment for Autism Spectrum Disorder in Children: A Double-blind Randomised Placebo-controlled Trial With Open Label Extension (FOLIN-A Trial)
Run by KK Women's and Children's Hospital · NCT07630506 · Data updated 2026-11-12
This study tests whether folinic acid given to children with autism helps improve symptoms compared with a placebo.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 3 Years to 10 Years |
| Sex | All |
| Enrollment | 184 (estimated) |
| Sponsor | KK Women's and Children's Hospital Government |
| Drugs / interventions | methotrexate |
| Locations | 1 site (Singapore, Singapore) |
| Status | Recruiting |
| Started | May 19, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT07630506 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 3 through 10 years 11 months with a confirmed ASD diagnosis, stable behavioral interventions, and weight between 10 and 30 kg.
✕Probably not a fit
Children who do not respond to folinic acid or who experience adverse effects may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a phase 2, double-blind, randomized, placebo-controlled trial in children with autism spectrum disorder. Participants will receive either folinic acid 2 mg/kg/day or a matching placebo for 12 weeks, without anyone knowing which treatment is being given. After the blinded period, all participants may receive folinic acid during a 12-week open-label extension to examine longer-term safety and potential benefits. The trial aims to determine if folinic acid can improve core autism symptoms and overall functioning in children.
Why it matters
Potential benefit: If successful, children may experience improvements in communication, behavior, and social interaction.
How similar studies have gone: Prior similar trials in this area have explored folate-related therapies, with mixed results; this study contributes additional evidence in a rigorous design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 3 years 0 months to 10 years 11 months at the time of enrolment * Weight ≥ 10 kg and ≤ 30 kg at the time of enrolment * Confirmed diagnosis of Autism Spectrum Disorder (ASD) based on Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) or Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria, supported by standardized diagnostic assessments * Stable on regular behavioral interventions and any medications for at least 6 months prior to enrolment * At least one parent or legal guardian able to understand and complete study questionnaires in English * Written informed consent obtained from a parent or legal guardian Exclusion Criteria: * Known allergy or intolerance to folinic acid * Current or prior supplementation with folinic acid or other folate preparations (folic acid supplementation permitted) * Vitamin B12 (cobalamin) deficiency or pernicious anemia * Concurrent use of medications known to interfere with folate metabolism (e.g., methotrexate, trimethoprim, fluorouracil, capecitabine, glucarpidase) * Known genetic, metabolic, or chromosomal disorder, or structural brain abnormalities * History of epilepsy or seizures (except simple febrile seizures) or current use of antiepileptic or antipsychotic medication * Significant sensory (hearing or visual) or motor impairment * Participation in another interventional clinical trial for autism within the past 6 months * Unable or unwilling to comply with study visits and procedures
Where it's running
-
KK Women's and Children's Hospital
Singapore, Singapore, Singapore Recruiting
Study contacts
- Study coordinator: Study Coordinator
- Email: folin-a@kkh.com.sg
- Phone: 6563947201
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sensory Integration and Deep Pressure Therapy for Motor Coordination in Children with ASD
This study tests whether combining Sensory Integration Therapy with Deep Pressure Therapy can improve motor coordination and reduce repetitive behaviors in children aged 4–10 with autism.
-
Pupillometer screen to help identify autism in kids aged 2–4 during routine visits
A handheld pupillometer test is being tried to see if it can help identify autism in young children during regular pediatric visits.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Heart Rate Variability Biofeedback for Anxiety in Autistic Youth
This study tests a wearable heart rate variability biofeedback tool to see if it helps reduce anxiety in autistic teens.
-
Structured Sensory-Based Occupational Therapy for Children with Autism
This study tests a 12-week, 40-minute sensory-based occupational therapy program twice a week to see if it improves daily skills, sensory processing, movement, and eating in children aged 3-9 with autism.
-
Exergaming and Aerobic Exercise for Kids with Autism
This study tests whether adding exergames or aerobic exercise to a standard program helps improve sleep, movement skills, thinking skills, and brain activity in children with autism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.